![1]()
News
Coronary CT angiography radiation dose fell 78% from 2007-2017
September 11, 2018
MUNICH – A 2017 survey of coronary CT angiography radiation doses for 4,502 patients at 61 worldwide sites showed a 78% drop compared with 2007.
![1]()
News
Danish endocarditis strategy halved hospital days
September 10, 2018
MUNICH – POET trial shows early discharge after switch from intravenous to oral antibiotics is safe and effective.
![1]()
News
Rivaroxaban superior to aspirin for extended VTE treatment
August 29, 2018
Researchers said there is no longer a place for aspirin in extended VTE treatment.
News
Declining lung function linked to heart failure, stroke
August 28, 2018
Cardiologists and pulmonologists should collaborate to better identify the relationship between lung function decline and early CV disease detection.
![1]()
News
New MI definition aims to better distinguish infarction from injury
August 28, 2018
MUNICH – By endorsing high sensitivity cardiac troponin and cardiac MR as diagnostic cornerstones, the new MI definition stands to change U.S. practice.
News
Rivaroxaban no help for heart failure outcomes
August 27, 2018
MUNICH - Rivaroxaban did not change outcome in patients with heart failure and coronary artery disease in the COMMANDER trial.
News
VTE risk unchanged by rivaroxaban after discharge
August 26, 2018
The MARINER study looked at postdischarge rivaroxaban in individuals who had been recently hospitalized and were at an increased risk of venous thromboembolism.
News
New Valsalva maneuver for SVT beats all others
August 21, 2018
NEW ORLEANS – A simple postural modification to the standard Valsalva maneuver boosts conversion rate.
![1]()
News
AHA: Chagas disease and its heart effects have come to the U.S.
August 20, 2018
Chagas disease and its related cardiomyopathy are spreading to nonendemic areas and doctors should be aware of its diagnosis, pathology, and treatment.
![1]()
News
Prepare for ‘the coming tsunami’ of NAFLD
August 16, 2018
NEW ORLEANS – It’s time for primary care physicians to stop ignoring NASH, an expert says.
